Cargando…

Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Pavel-Dinu, Mara, Wiebking, Volker, Dejene, Beruh T., Srifa, Waracharee, Mantri, Sruthi, Nicolas, Carmencita E., Lee, Ciaran, Bao, Gang, Kildebeck, Eric J., Punjya, Niraj, Sindhu, Camille, Inlay, Matthew A., Saxena, Nivedita, DeRavin, Suk See, Malech, Harry, Roncarolo, Maria Grazia, Weinberg, Kenneth I., Porteus, Matthew H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890644/ https://www.ncbi.nlm.nih.gov/pubmed/31796738 http://dx.doi.org/10.1038/s41467-019-13620-5

Ejemplares similares

Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells
por: Pavel-Dinu, Mara, et al.
Publicado: (2019)

Gene correction for SCID-X1 in long-term hematopoietic stem cells
por: Pavel-Dinu, Mara, et al.
Publicado: (2019)

Cas9-AAV6-engineered human mesenchymal stromal cells improved cutaneous wound healing in diabetic mice
por: Srifa, Waracharee, et al.
Publicado: (2020)

Genome editing of donor-derived T cells to generate allogeneic chimeric antigen receptor-modified T cells: optimizing αβ T-cell-depleted haploidentical hematopoietic stem cell transplantation
por: Wiebking, Volker, et al.
Publicado: (2020)

Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease
por: Park, So Hyun, et al.
Publicado: (2019)

Correction of X-CGD patient HSPCs by targeted CYBB cDNA insertion using CRISPR/Cas9 with 53BP1 inhibition for enhanced homology-directed repair
por: Sweeney, Colin L., et al.
Publicado: (2021)

Abstract 100: Human Mesenchymal Stromal Cells Engineered to Overexpress PDGF-B Using CRISPR/Cas9/rAAV6-based Tools Improve Wound Healing
por: Kosaric, Nina, et al.
Publicado: (2017)

Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I
por: Gomez-Ospina, Natalia, et al.
Publicado: (2019)

Correction of recessive dystrophic epidermolysis bullosa by homology-directed repair-mediated genome editing
por: Bonafont, Jose, et al.
Publicado: (2021)

Expanding the Repertoire of Target Sites for Zinc Finger Nuclease-mediated Genome Modification
por: Wilson, Kimberly A, et al.
Publicado: (2013)

Multiplex HDR for disease and correction modeling of SCID by CRISPR genome editing in human HSPCs
por: Iancu, Ortal, et al.
Publicado: (2022)

Genetics of SCID
por: Cossu, Fausto
Publicado: (2010)

Correction to: PEGylated Recombinant Adenosine Deaminase Maintains Detoxification and Lymphocyte Counts in Patients with ADA-SCID
por: Dorsey, Morna J., et al.
Publicado: (2023)

Analyses of thymocyte commitment to regulatory T cell lineage in thymus of healthy subjects and patients with 22q11.2 deletion syndrome
por: Borna, Simon, et al.
Publicado: (2023)

Interleukin-27 Enhances the Potential of Reactive Oxygen Species Generation from Monocyte-derived Macrophages and Dendritic cells by Induction of p47(phox)
por: Sowrirajan, Bharatwaj, et al.
Publicado: (2017)

A Curative DNA Code for Hematopoietic Defects Novel Cell Therapies for Monogenic Diseases of the Blood and Immune System
por: Porteus, Matthew H., et al.
Publicado: (2022)

Author Correction: Metabolite and thymocyte development defects in ADA-SCID mice receiving enzyme replacement therapy
por: Moretti, Federico A., et al.
Publicado: (2021)

Correction to: Efficient derivation of extended pluripotent stem cells from NOD-scid Il2rg(−/−) mice
por: Du, Yaqin, et al.
Publicado: (2018)

Differential Secondary Reconstitution of In Vivo-Selected Human SCID-Repopulating Cells in NOD/SCID versus NOD/SCID/γ chain(null) Mice
por: Cai, Shanbao, et al.
Publicado: (2011)

Gene therapy for ADA‐SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products
por: Aiuti, Alessandro, et al.
Publicado: (2017)

Implementation of SCID Screening in Denmark
por: Bækvad-Hansen, Marie, et al.
Publicado: (2021)

Author Correction: Investigation of Cas9 antibodies in the human eye
por: Toral, Marcus A., et al.
Publicado: (2022)

Correction: Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6
por: Bak, Rasmus O, et al.
Publicado: (2018)

Clinical Spectrum of SCID: The Key is in the Thymus?
por: van der Burg, Mirjam, et al.
Publicado: (2014)

Neonatal Screening for SCID: The French Experience
por: Audrain, Marie, et al.
Publicado: (2021)

Anti-SCID mouse reactivity shapes the human CD4+ T cell repertoire in hu-PBL-SCID chimeras
Publicado: (1994)

A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human haematopoietic stem and progenitor cells
por: Vakulskas, Christopher A., et al.
Publicado: (2018)

Correction: D Quantification of Tumor Vasculature in Lymphoma Xenografts in NOD/SCID Mice Allows to Detect Differences among Vascular-Targeted Therapies
por: Righi, Marco, et al.
Publicado: (2013)

Correction: Amniotic Mesenchymal Stem Cells Enhance Wound Healing in Diabetic NOD/SCID Mice through High Angiogenic and Engraftment Capabilities
por: Kim, Sung-Whan, et al.
Publicado: (2012)

Correction: Amniotic Mesenchymal Stem Cells Enhance Wound Healing in Diabetic NOD/SCID Mice through High Angiogenic and Engraftment Capabilities
por: Kim, Sung-Whan, et al.
Publicado: (2012)

Correction: Amniotic Mesenchymal Stem Cells Enhance Wound Healing in Diabetic NOD/SCID Mice through High Angiogenic and Engraftment Capabilities
por: Kim, Sung-Whan, et al.
Publicado: (2012)

Pancreatic Insulin-Producing Cells Differentiated from Human Embryonic Stem Cells Correct Hyperglycemia in SCID/NOD Mice, an Animal Model of Diabetes
por: Hua, Xiu-feng, et al.
Publicado: (2014)

CRISPR-Cas9-AAV versus lentivector transduction for genome modification of X-linked severe combined immunodeficiency hematopoietic stem cells
por: Brault, Julie, et al.
Publicado: (2023)

Gene therapy of destructive arthritis in SCID mice
por: Sack, U, et al.
Publicado: (2003)

Newborn Screening for SCID. Experience in Spain (Catalonia)
por: Argudo-Ramírez, Ana, et al.
Publicado: (2021)

X-linked SCID with a rare mutation
por: Mahdavi, Fatemeh Sadat, et al.
Publicado: (2021)

Homozygous scid/scid;beige/beige mice have low levels of spontaneous or neonatal T cell-induced B cell generation
Publicado: (1993)

‘I stand corrected’
por: Shikhare, Sumer N, et al.
Publicado: (2015)

Correction: Glutamate Concentration in the Medial Prefrontal Cortex Predicts Resting-State Cortical-Subcortical Functional Connectivity in Humans
por: Duncan, Niall W., et al.
Publicado: (2013)

Author Correction: Engineering monocyte/macrophage−specific glucocerebrosidase expression in human hematopoietic stem cells using genome editing
por: Scharenberg, Samantha G., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6s9t2ds4sisobbhilhldpuvt98